Scarica l'app Stockscreener
5.81
6.61%
0.36
Dopo l'orario di chiusura:
5.89
0.08
+1.38%
Orchestra Biomed Holdings Inc Borsa (OBIO) Ultime notizie
Orchestra BioMed Shares Rise After BTIG Upgrade - marketscreener.com
Orchestra BioMed at Wells Fargo: partnership model in focus By Investing.com - Investing.com Canada
Crude Oil Surges 6%; Macy’s Shares Fall After Q2 Results - Benzinga
Wealthfront, Orchestra Biomed, AeroVironment And Other Big Stocks Moving Higher On Thursday - Benzinga
This Meta Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday - Benzinga
BTIG Upgrades Orchestra BioMed to Buy From Neutral, Price Target is $10 - marketscreener.com
BTIG upgrades Orchestra BioMed stock rating on trial progress By Investing.com - Investing.com Canada
BTIG upgrades Orchestra BioMed stock rating on trial progress - Investing.com
Orchestra BioMed CEO David Hochman buys $47,900 in common stock By Investing.com - Investing.com India
Orchestra BioMed Highlights Pivotal Cardiovascular Program Progress - TipRanks
Orchestra BioMed presents investor slide deck detailing AVIM and Virtue SAB programs, strategic partners and 2027 catalysts - TradingView
Orchestra BioMed CEO David Hochman buys $47,900 in common stock - Investing.com
Orchestra BioMed (OBIO) CEO buys more of his own stock - Stock Titan
Orchestra BioMed Grants 133,000 Options to New Hires - mychesco.com
Orchestra BioMed (OBIO) president sells 15,000 shares under trading plan - Stock Titan
Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
Insider plans to sell 15,000 Orchestra BioMed (OBIO) shares - Stock Titan
Orchestra BioMed (OBIO) CFO logs 3,076-share tax withholding - Stock Titan
Orchestra BioMed (NASDAQ: OBIO) exec cites tax share withholding and son's 2,000-share buy - Stock Titan
Orchestra BioMed (OBIO) officer sees shares withheld for RSU taxes - Stock Titan
Avoiding Lag: Real-Time Signals in (OBIO) Movement - Stock Traders Daily
Orchestra BioMed to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - GlobeNewswire
Orchestra BioMed to Participate in the Wells Fargo 21st Annual Healthcare Conference - GlobeNewswire
Insiders Buying Orchestra BioMed Holdings Might Wish They Invested More, Stock Gains 29% - Moomoo
Orchestra (OBIO) Q2 2026 Results: Profit Per Share Clears Its Benchmark for the Current Session; Investor Response: Shares Finish 19.92% Higher in Latest TradingInvestor Earnings Call - vinanet.vn
Orchestra (OBIO) Reported Results Review: EPS Prints Above Forecast for the Current Session; Price Action: Shares Close 19.92% Higher at the CloseProfit Recovery Report - vinanet.vn
Orchestra BioMed Loss Widens as Pivotal Trials Advance - MyChesCo
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Orchestra BioMed (OBIO) director withholds 3,761 shares to cover RSU tax bill - Stock Titan
Orchestra BioMed (OBIO) director uses 5,145 shares to cover RSU tax withholding - Stock Titan
Orchestra BioMed (OBIO) director has 4,885 shares withheld for RSU tax - Stock Titan
Orchestra BioMed (OBIO) director reports 4,238 RSU tax-withholding shares - Stock Titan
Orchestra BioMed (OBIO) Holds Gains at $4.45, Consolidating Between Key Technical LevelsComposite Profile - vinanet.vn
Research Analysts Offer Predictions for OBIO Q3 Earnings - MarketBeat
Wall Street Analysts Are Bullish on Top Healthcare Picks - theglobeandmail.com
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Consensus Forecasts Have Become A Little Darker Since Its Latest Report - simplywall.st
Piper Sandler Maintains Orchestra BioMed(OBIO.US) With Buy Rating, Raises Target Price to $10 - Moomoo
Orchestra BioMed Holdings, Inc. Stock 12‑Month Price Target Raised to $12.33, Implies 177% Upside - TradingView
Orchestra Biomed Holdings earnings beat by $0.01, revenue fell short of estimates - Investing.com Canada
Orchestra Biomed Holdings Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Orchestra BioMed Reports Second Quarter 2026 Financial Results and Highlights Recent Business Updates - Investing News Network
OBIO Looks 87.4% Undervalued on GF Value™ Despite Challenging Fu - GuruFocus
Orchestra BioMed reports $24.1M Q2 loss, secures $35M capital - scanx.trade
Orchestra BioMed Holdings, Inc. (OBIO) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance
Orchestra BioMed (NASDAQ:OBIO) Announces Quarterly Earnings Results, Misses Estimates By $0.03 EPS - MarketBeat
Orchestra BioMed Reports Q2 2026 Results and Updates Progress on BACKBEAT and Virtue Pivotal Trials - Moomoo
Orchestra BioMed (NASDAQ: OBIO) widens H1 2026 loss amid heavy R&D spend - Stock Titan
Orchestra BioMed (OBIO) Climbs 1.56% to $4.31 as Shares Hold Above Key SupportCharm Flow - dars.gov.et
Orchestra Biomed Holdings Inc (OBIO) Stock News Today - TradingKey
Orchestra Biomed Holdings Inc (OBIO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Orchestra BioMed (OBIO) Insider Darren Sherman Sells 15,000 Shar - GuruFocus
Darren Sherman Sells 15,000 Shares of Orchestra BioMed (NASDAQ:OBIO) Stock - marketbeat.com
Orchestra BioMed (OBIO) insider sale under 10b5-1 plan on August 3, 2026 - Stock Titan
Orchestra BioMed (OBIO) Projected to Announce Quarterly Earnings on Tuesday - marketbeat.com
Orchestra BioMed (NASDAQ: OBIO) insider details Rule 144 sales of 45,000 shares - Stock Titan
Orchestra BioMed (OBIO) Holds Near $4.00 as Shares Test Support ZoneAnalyst Upgrade Stocks - vinanet.vn
Orchestra Biomed Holdings Inc expected to post a loss of 39 cents a shareEarnings Preview - TradingView
OBIO|Orchestra Biomed Holdings Inc|Price:3.825|Chg%:+0.085 - TradingKey
Orchestra Biomed Holdings Inc (OBIO) Income Statement - TradingKey
Orchestra Biomed Holdings Inc (OBIO) Balance Sheet - TradingKey
Orchestra Biomed Holdings Inc (OBIO) Institutional Confidence - TradingKey
Orchestra Biomed Holdings Inc (OBIO) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
3.04%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):